• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.23% Nasdaq Up 0.17%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    0.41 Down 0.02(5.24%) 12:37PM EDT - Nasdaq Real Time Price
    Prev Close:0.44
    Open:0.44
    Bid:0.41 x 800
    Ask:0.41 x 100
    1y Target Est:1.52
    Beta:2.34155
    Next Earnings Date:N/A
    Day's Range:0.41 - 0.45
    52wk Range:0.39 - 6.96
    Volume:2,394,384
    Avg Vol (3m):2,417,250
    Market Cap:60.00M
    P/E (ttm):N/A
    EPS (ttm):-0.52
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    ┬╗ More Headlines for OREX

    Comparison

    Symbol% ChgMkt Cap
    OREXDown 5.24%60.00M
    GSKUp 0.27%102.77B
    ABTUp 0.75%56.41B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.59
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.52
    Quarterly EPS Est (Jun-16) :-0.11
    Mean Recommendation*:3.1
    PEG Ratio (5 yr expected):0.01

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products. The company offers Contrave for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback